Comparison of fumaric acid ester-PUVA versus PUVA-etretinate in palmoplantar pustolosis
Phase 1
- Conditions
- Psoriasis pustulosis palmoplantaris
- Registration Number
- EUCTR2006-004519-23-AT
- Lead Sponsor
- Medizinische Universität Wien, Univ.Klinik für Dermatologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with a psoriasis pustulosis palmoplantaris
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Immunsuppresion; Pregnancy and period of breast feeding; women capabled of childbearing age without contraception; malfunction of liver, kidney insufficience; systhemical or topical treatment in the last 2 or 4 weeks; any specific disease treatment;hyperlipidämie;persons under the age of 18 years
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method